Metastatic melanoma and vemurafenib: novel approaches
Metastatic melanoma (MM) presents a treatment challenge to oncologists worldwide. Dacarbazine is the first line chemotherapy treatment for MM, though the overall response rates are very poor. Recently, the v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600 mutation was found to play a main r...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
PAGEPress Publications
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401159/ |